LAPORAN KASUS: ROSASEA TIPE PAPULOPUSTULAR YANG DITERAPI DOKSISIKLIN ORAL, ASAM AZALEAT DAN RETINOID TOPIKAL
DOI:
https://doi.org/10.33820/mdvi.v51i2.290Keywords:
eritema, inflamasi, papulopustular, rosasea, telangiektasisAbstract
ABSTRAK
Rosasea merupakan suatu kondisi inflamasi kronis pada kulit bersifat kambuhan yang mengenai daerah sentrofasial (hidung, dagu, pipi, dahi dan glabela). Secara klinis, rosasea ditandai oleh adanya eritema (transien hingga persisten), telangiektasis, papul, pustul dan perubahan fimatosa. Tanda klinis tersebut disertai rasa gatal, terbakar, tersengat atau nyeri. Di RSUP Sanglah Denpasar sejak Januari 2019 sampai Desember 2021 tercatat sebanyak 5 kasus rosasea dengan tipe papulopustular.
Laki-laki, usia 49 tahun, suku Jawa, Warga Negara Indonesia, muncul kemerahan pada kedua pipi, dagu, hidung dan dahi disertai benjolan kecil seperti jerawat berwarna kemerahan dan sebagian berisi nanah disertai rasa nyeri seperti terbakar dan gatal sejak 2 tahun yang lalu. Riwayat sering terpajan sinar matahari. Pasien mengaku gemar makan makanan pedas, berkuah panas seperti sup atau soto, serta meminum kopi panas setiap pagi. Diagnosis rosasea ditegakkan berdasarkan anamnesis, gejala klinis, pemeriksaan dermoskopi dan histopatologi. Tatalaksana berupa doksisiklin 100 mg tiap 12 jam intra oral, asam azaleat 20% gel topikal tiap 24 jam (pagi hari), tabir surya topikal dengan Sun Protector Factor (SPF) 45, tretinoin 0,025% krim topikal tiap 24 jam memberikan perbaikan klinis pada minggu ketujuh. Terapi yang tepat dan menghindari faktor pencetus umumnya dapat mengurangi kekambuhan rosasea.
Kata kunci: eritema, inflamasi, papulopustular, rosasea, telangiektasis
Downloads
References
1. Kang S, Amagai M, Bruckner AL, Enk AH, Margolis DJ, McMichael AJ OJ. Fitzpatrick’s Dermatology Ninth Edition. 2019. p.1419–1443.
2. Saghari, Keri, Shamler, Baumann. Cosmetic Dermatology second ed. Dermatology. Illustrated Study Guide and Comprehensive Board Review. 2009. p.128–132.
3. Rainer BM, Kang S, Chien AL. Rosacea: Epidemiology, pathogenesis, and treatment. Dermatoendocrinol. 2017;9(1):1-13.
4. Tan J, Schöfer H, Araviiskaia E, Audibert F, Kerrouche N, Berg M. Prevalence of rosacea in the general population of Germany and Russia - The RISE study. J Eur Acad Dermatology Venereol. 2016;30(3):428–34.
5. Fernandes A, Indramaya DM. Studi retrospektif : profil penyakit rosacea (Retrospective study : profile of rosacea). BIKKK - Berk Ilmu Kesehat Kulit dan Kelamin - Period Dermatology Venereol. 2015;30(2):145–53.
6. Vella, Taufiq AV, Suyoso S. Klasifikasi Baru dan Patogenesis Rosasea. Berk Ilmu Kesehat Kulit dan Kelamin. 2011;22(2):127–34.
7. Gallo RL, Granstein RD, Kang S, Mannis M, Steinhoff M, Tan J, et al. Standard classification and pathophysiology of rosacea: The 2017 update by the National Rosacea Society Expert Committee. J Am Acad Dermatol [Internet]. 2018;78(1):148–55. Available from: https://doi.org/10.1016/j.jaad.2017.08.037
8. Buddenkotte, Steinhoff. Recent advances in understanding and managing chordomas. F1000Research. 2018;7(1885):1–10.
9. Gonçalves MMBDMM, De Pina MESRT. Dermocosmetic care for rosacea. Brazilian J Pharm Sci. 2017;53(4):1–16.
10. Kang IH, Seo JK SM. Useful Dermoscopic Finds for Differentiating Rosacea from Seborrheic Dermatitis. Indian J Dermatol [Internet]. 2020;65:316–8. Available from: https://doi.org/10.4103/ijd.IJD_44_19
11. Errichetti E. Dermoscopy in Monitoring and Predicting Therapeutic Response in General Dermatology (Non-Tumoral Dermatoses): An Up-To-Date Overview. Dermatol Ther (Heidelb) [Internet]. 2020;10(6):1199–214. Available from: https://doi.org/10.1007/s13555-020-00455-y
12. Deshapande A, Ankad BS. Dermoscopic Monitoring of Response to Intense Pulsed Light in Rosacea: A Case Report. Dermatol Pract Concept. 2020;10(3):e2020058.
13. Mikkelsen CS, Bjerring P, Holmgren HR, Salava A. Rosacea : Time for a New Approach Review Rosacea : Time for a New Approach. 2017;(May).
14. Forton FMN. The Pathogenic Role of Demodex Mites in Rosacea: A Potential Therapeutic Target Already in Erythematotelangiectatic Rosacea? Dermatol Ther (Heidelb) [Internet]. 2020;10(6):1229–53. Available from: https://doi.org/10.1007/s13555-020-00458-9
15. Cribier B. Rosacea under the microscope: Characteristic histological findings. J Eur Acad Dermatology Venereol. 2013;27(11):1336–43.
16. Abokwidir M, Feldman SR. Rosacea Management. Ski Appendage Disord. 2016;2(1–2):26–34.
17. Oge LK, State L, Muncie LHL, Medicine F, Orleans N, Phillips-savoy LAR, et al. Rosacea: Diagnosis and Treatment. 2015;
18. Maor D, Chong AH. Rosacea. Aust Fam Physician. 2017;46(5):277–81.
19. Asai Y, Tan J, Baibergenova A, Barankin B, Cochrane CL, Humphrey S, et al. Canadian clinical practice guidelines for rosacea. J Cutan Med Surg. 2016;20(5):432–45.
20. Rosso JQ Del, Thiboutot D, Gallo R, Webster G, Tanghetti E, Eichenfield LF, et al. Consensus Recommendations From the American Acne & Rosacea Society on the Management of Rosacea , Part 1 : A Status Report on the Disease State , General Measures , and Adjunctive Skin Care. Cutis. 2013;
21. Rosso D, Bhatia. Azelaic Acid gel 15% in the Management of Papulopustular Rosacea: a Status Report on Available Efficacy Data and Clinical Application. Cutis. 2011;88:67–72.
22. Engin B, Özkoca D, Kutlubay Z, Serdaroğlu S. Conventional and novel treatment modalities in rosacea. Clin Cosmet Investig Dermatol. 2020;13:179–86.
23. Rusu A, Tanase C, Pascu GA, Todoran N. Recent advances regarding the therapeutic potential of adapalene. Pharmaceuticals. 2020;13(9):1–22.
24. Kryczyk-Poprawa A, Kwiecień A, Opoka W. Photostability of topical agents applied to the skin: A review. Pharmaceutics. 2020;12(1).
25. Altinyazar HC, Koca R, Tekin NS, Eştürk E. Adapalene vs. metronidazole gel for the treatment of rosacea. Int J Dermatol. 2005;44(3):252–5.
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Media Dermato-Venereologica Indonesiana
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
